Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Innospec (IOSP) over the last 2 years, with Q3 2025 value amounting to $22.9 million.

  • Innospec's Asset Writedowns and Impairment changed N/A to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $19.8 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Innospec reported Asset Writedowns and Impairment of $22.9 million as of Q3 2025.
  • Over the past 5 years, Innospec's Asset Writedowns and Impairment peaked at $22.9 million during Q3 2025, and registered a low of $22.9 million during Q3 2025.